Cargando…
Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells
The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SA...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423671/ https://www.ncbi.nlm.nih.gov/pubmed/34517212 http://dx.doi.org/10.1016/j.bbrc.2021.09.015 |
_version_ | 1783749514417405952 |
---|---|
author | Sasaki, Michihito Kishimoto, Mai Itakura, Yukari Tabata, Koshiro Intaruck, Kittiya Uemura, Kentaro Toba, Shinsuke Sanaki, Takao Sato, Akihiko Hall, William W. Orba, Yasuko Sawa, Hirofumi |
author_facet | Sasaki, Michihito Kishimoto, Mai Itakura, Yukari Tabata, Koshiro Intaruck, Kittiya Uemura, Kentaro Toba, Shinsuke Sanaki, Takao Sato, Akihiko Hall, William W. Orba, Yasuko Sawa, Hirofumi |
author_sort | Sasaki, Michihito |
collection | PubMed |
description | The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SARS-CoV-2 entry receptor: angiotensin-converting enzyme-2 (ACE2). Here, we examined SARS-CoV-2 susceptibility to A549 cells after adaptation to air-liquid interface (ALI) culture. A549 cells in ALI culture yielded a layer of mucus on their apical surface, exhibited decreased expression levels of the proliferation marker KI-67 and intriguingly became susceptible to SARS-CoV-2 infection. We found that A549 cells increased the endogenous expression levels of ACE2 and TMPRSS2 following adaptation to ALI culture conditions. Camostat, a TMPRSS2 inhibitor, reduced SARS-CoV-2 infection in ALI-cultured A549 cells. These findings indicate that ALI culture switches the phenotype of A549 cells from resistance to susceptibility to SARS-CoV-2 infection through upregulation of ACE2 and TMPRSS2. |
format | Online Article Text |
id | pubmed-8423671 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-84236712021-09-08 Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells Sasaki, Michihito Kishimoto, Mai Itakura, Yukari Tabata, Koshiro Intaruck, Kittiya Uemura, Kentaro Toba, Shinsuke Sanaki, Takao Sato, Akihiko Hall, William W. Orba, Yasuko Sawa, Hirofumi Biochem Biophys Res Commun Article The human lung cell A549 is susceptible to infection with a number of respiratory viruses. However, A549 cells are resistant to Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) infection in conventional submerged culture, and this would appear to be due to low expression levels of the SARS-CoV-2 entry receptor: angiotensin-converting enzyme-2 (ACE2). Here, we examined SARS-CoV-2 susceptibility to A549 cells after adaptation to air-liquid interface (ALI) culture. A549 cells in ALI culture yielded a layer of mucus on their apical surface, exhibited decreased expression levels of the proliferation marker KI-67 and intriguingly became susceptible to SARS-CoV-2 infection. We found that A549 cells increased the endogenous expression levels of ACE2 and TMPRSS2 following adaptation to ALI culture conditions. Camostat, a TMPRSS2 inhibitor, reduced SARS-CoV-2 infection in ALI-cultured A549 cells. These findings indicate that ALI culture switches the phenotype of A549 cells from resistance to susceptibility to SARS-CoV-2 infection through upregulation of ACE2 and TMPRSS2. Elsevier Inc. 2021-11-05 2021-09-08 /pmc/articles/PMC8423671/ /pubmed/34517212 http://dx.doi.org/10.1016/j.bbrc.2021.09.015 Text en © 2021 Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sasaki, Michihito Kishimoto, Mai Itakura, Yukari Tabata, Koshiro Intaruck, Kittiya Uemura, Kentaro Toba, Shinsuke Sanaki, Takao Sato, Akihiko Hall, William W. Orba, Yasuko Sawa, Hirofumi Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title_full | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title_fullStr | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title_full_unstemmed | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title_short | Air-liquid interphase culture confers SARS-CoV-2 susceptibility to A549 alveolar epithelial cells |
title_sort | air-liquid interphase culture confers sars-cov-2 susceptibility to a549 alveolar epithelial cells |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423671/ https://www.ncbi.nlm.nih.gov/pubmed/34517212 http://dx.doi.org/10.1016/j.bbrc.2021.09.015 |
work_keys_str_mv | AT sasakimichihito airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT kishimotomai airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT itakurayukari airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT tabatakoshiro airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT intaruckkittiya airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT uemurakentaro airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT tobashinsuke airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT sanakitakao airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT satoakihiko airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT hallwilliamw airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT orbayasuko airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells AT sawahirofumi airliquidinterphasecultureconferssarscov2susceptibilitytoa549alveolarepithelialcells |